PortfoliosLab logoPortfoliosLab logo
UTHR vs. OPXS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

UTHR vs. OPXS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Optex Systems Holdings Inc. Common Stock (OPXS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

UTHR vs. OPXS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
21.70%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
OPXS
Optex Systems Holdings Inc. Common Stock
-6.73%106.71%4.66%122.19%57.75%5.06%-9.64%50.38%23.80%70.34%

Fundamentals

EPS

UTHR:

$27.90

OPXS:

-$6.00

PS Ratio

UTHR:

8.91

OPXS:

0.02

Total Revenue (TTM)

UTHR:

$3.18B

OPXS:

$4.07B

Gross Profit (TTM)

UTHR:

$2.80B

OPXS:

$772.93M

EBITDA (TTM)

UTHR:

$1.82B

OPXS:

-$25.40M

Returns By Period

In the year-to-date period, UTHR achieves a 21.70% return, which is significantly higher than OPXS's -6.73% return. Both investments have delivered pretty close results over the past 10 years, with UTHR having a 18.04% annualized return and OPXS not far ahead at 18.61%.


UTHR

1D
0.79%
1M
17.68%
YTD
21.70%
6M
41.45%
1Y
92.36%
3Y*
38.34%
5Y*
25.25%
10Y*
18.04%

OPXS

1D
3.16%
1M
2.12%
YTD
-6.73%
6M
2.60%
1Y
132.83%
3Y*
62.19%
5Y*
48.36%
10Y*
18.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. OPXS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 9393
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9494
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9595
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9494
Martin Ratio Rank

OPXS
OPXS Risk / Return Rank: 8787
Overall Rank
OPXS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
OPXS Sortino Ratio Rank: 8787
Sortino Ratio Rank
OPXS Omega Ratio Rank: 8282
Omega Ratio Rank
OPXS Calmar Ratio Rank: 8888
Calmar Ratio Rank
OPXS Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. OPXS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Optex Systems Holdings Inc. Common Stock (OPXS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTHROPXSDifference

Sharpe ratio

Return per unit of total volatility

1.84

1.83

+0.01

Sortino ratio

Return per unit of downside risk

3.30

2.52

+0.77

Omega ratio

Gain probability vs. loss probability

1.46

1.30

+0.16

Calmar ratio

Return relative to maximum drawdown

5.70

3.47

+2.23

Martin ratio

Return relative to average drawdown

14.49

9.20

+5.29

UTHR vs. OPXS - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.84, which is comparable to the OPXS Sharpe Ratio of 1.83. The chart below compares the historical Sharpe Ratios of UTHR and OPXS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


UTHROPXSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.84

1.83

+0.01

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.72

0.91

-0.19

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

0.31

+0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

-0.09

+0.48

Correlation

The correlation between UTHR and OPXS is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

UTHR vs. OPXS - Dividend Comparison

Neither UTHR nor OPXS has paid dividends to shareholders.


TTM202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
OPXS
Optex Systems Holdings Inc. Common Stock
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.05%3.64%

Drawdowns

UTHR vs. OPXS - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, smaller than the maximum OPXS drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for UTHR and OPXS.


Loading graphics...

Drawdown Indicators


UTHROPXSDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-99.87%

+6.69%

Max Drawdown (1Y)

Largest decline over 1 year

-16.35%

-39.26%

+22.91%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-45.68%

+12.68%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

-78.31%

+22.75%

Current Drawdown

Current decline from peak

0.00%

-96.92%

+96.92%

Average Drawdown

Average peak-to-trough decline

-35.53%

-95.70%

+60.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.43%

14.79%

-8.36%

Volatility

UTHR vs. OPXS - Volatility Comparison

United Therapeutics Corporation (UTHR) has a higher volatility of 17.05% compared to Optex Systems Holdings Inc. Common Stock (OPXS) at 14.06%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than OPXS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


UTHROPXSDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.05%

14.06%

+2.99%

Volatility (6M)

Calculated over the trailing 6-month period

26.84%

50.04%

-23.20%

Volatility (1Y)

Calculated over the trailing 1-year period

50.41%

73.06%

-22.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.89%

53.35%

-17.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.32%

60.60%

-25.28%

Financials

UTHR vs. OPXS - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Optex Systems Holdings Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
790.20M
4.04B
(UTHR) Total Revenue
(OPXS) Total Revenue
Values in USD except per share items

UTHR vs. OPXS - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and Optex Systems Holdings Inc. Common Stock over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
86.9%
18.9%
Portfolio components
UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported a gross profit of 686.80M and revenue of 790.20M. Therefore, the gross margin over that period was 86.9%.

OPXS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Optex Systems Holdings Inc. Common Stock reported a gross profit of 763.00M and revenue of 4.04B. Therefore, the gross margin over that period was 18.9%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported an operating income of 356.70M and revenue of 790.20M, resulting in an operating margin of 45.1%.

OPXS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Optex Systems Holdings Inc. Common Stock reported an operating income of -32.00M and revenue of 4.04B, resulting in an operating margin of -0.8%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported a net income of 364.30M and revenue of 790.20M, resulting in a net margin of 46.1%.

OPXS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Optex Systems Holdings Inc. Common Stock reported a net income of -32.00M and revenue of 4.04B, resulting in a net margin of -0.8%.